Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
Premium Land with House for Sale
anil1961
Updated:
Friday at 10:15 AM
AWS Certified Solutions Architect-Associate + AWS Certified Cloud Practitioner
Sanjeewani95
Updated:
Wednesday at 8:16 PM
🚀 එක පැකේජ් එකයි - මාසෙටම Unlimited Internet! 🌐
sayuru bandara
Updated:
Aug 18, 2026
🎬 CapCut Pro 1 Month Access! LKR 600
sayuru bandara
Updated:
Aug 18, 2026
🚀 Google One AI PRO Plan (Gemini Pro Activation) – 18 Months Access! LKR 2200
sayuru bandara
Updated:
Aug 18, 2026
Electronics
Vehicles
Property
Search
Reply to thread
Forums
General
Health & Lifestyle
අලුත් කොරෝනා වෛරස් ප්රභේද සහ අනාගතය
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="imhotep" data-source="post: 26707971" data-attributes="member: 562115"><p>There are many in the drug race. Apart from the above mentioned PF-07321332 protease inhibitor, Pfizer also has two other candidates based on their Main Protease (M-pro) technology. This was developed when SARS epidemic started and was later abandoned around 2004.</p><p>It was found with<strong> Covid</strong>, the Mpro remains almost the same as that of SARS pathogen, and they had only to make minor changes to the original chemicals. Two were prepared and one went ahead for trials - Both of these were IV administered. </p><p>Then all of a sudden they started testing a different Oral candidate PF-07321332 last month.</p><p></p><p>There are a few other antivirals from the US, Canada, to Australia. Them seem to work in-vitro but it will take years for human trials to be over and get approved.</p><p>The Australian developed drug uses Gene-silencing RNA technology, destroying the COVID virus genome directly and stops the virus replication but expected to be approved by 2023. Time is the issue...</p><p></p><p>Meanwhile Nasal vaccine or a drug might show a<strong> better promise</strong> - because that''s where the infection begins. Many researchers are onto this too.</p><p></p><p>PS: Note : Sometimes <strong>where you start attacking the virus </strong>matters. I have mentioned this before. A well known instance is the Polio Vaccine. Poliovirus is spread through food or water contaminated with human excrement. The virus enters the body through the <strong>mucosa of the gut</strong>.</p><p>Professor Jonas Salk developed the vaccine from completely inactivated virus which was injected, somewhere in 1955.</p><p></p><p>Later, in 1960, Albert Sabin introduced a new polio vaccine, with a weakened poliovirus.. (not inactivated like the Salk vaccine)</p><p><strong>But the most important thing to note was Sabin’s vaccine was swallowed</strong>, in the form of a sugar cube or a drop of liquid on a biscuit.</p><p>This method makes the vaccine into <strong>direct contact with the gut mucosa</strong>, with the result that it <strong>more effective than the Salk vaccine</strong> in blocking poliovirus infection.</p></blockquote><p></p>
[QUOTE="imhotep, post: 26707971, member: 562115"] There are many in the drug race. Apart from the above mentioned PF-07321332 protease inhibitor, Pfizer also has two other candidates based on their Main Protease (M-pro) technology. This was developed when SARS epidemic started and was later abandoned around 2004. It was found with[B] Covid[/B], the Mpro remains almost the same as that of SARS pathogen, and they had only to make minor changes to the original chemicals. Two were prepared and one went ahead for trials - Both of these were IV administered. Then all of a sudden they started testing a different Oral candidate PF-07321332 last month. There are a few other antivirals from the US, Canada, to Australia. Them seem to work in-vitro but it will take years for human trials to be over and get approved. The Australian developed drug uses Gene-silencing RNA technology, destroying the COVID virus genome directly and stops the virus replication but expected to be approved by 2023. Time is the issue... Meanwhile Nasal vaccine or a drug might show a[B] better promise[/B] - because that''s where the infection begins. Many researchers are onto this too. PS: Note : Sometimes [B]where you start attacking the virus [/B]matters. I have mentioned this before. A well known instance is the Polio Vaccine. Poliovirus is spread through food or water contaminated with human excrement. The virus enters the body through the [B]mucosa of the gut[/B]. Professor Jonas Salk developed the vaccine from completely inactivated virus which was injected, somewhere in 1955. Later, in 1960, Albert Sabin introduced a new polio vaccine, with a weakened poliovirus.. (not inactivated like the Salk vaccine) [B]But the most important thing to note was Sabin’s vaccine was swallowed[/B], in the form of a sugar cube or a drop of liquid on a biscuit. This method makes the vaccine into [B]direct contact with the gut mucosa[/B], with the result that it [B]more effective than the Salk vaccine[/B] in blocking poliovirus infection. [/QUOTE]
Insert quotes…
Verification
Asuwa dahayen wadi kalama keeyada?
Post reply
Top
Bottom